[Reuters] – YAVNE, Israel, Nov 26 (Reuters) – German healthcare group Merck KGaA is looking for acquisitions and collaborations with start-ups to grow its drugs business in the United States, a senior Merck official said. The drug and chemicals maker gets some 20 percent of pharmaceutical revenue from the United States, compared with an average of about 50 percent at most global pharma firms. “That’s where we want to be,” Stefan Oschmann, who heads up Merck’s pharmaceutical … [visit site to read more]
- Merck & Co. Inc. (NYSE:MRK) – Merck invests $107 million in China drug plant
- Market Update on Biogen Idec Inc. (NASDAQ:BIIB) – Biogen’s new MS drug tops sales expectations, earnings rise
- 3M Company (NYSE:MMM) – 3M Co profit rises 6 pct as sales grow
